{"id":"https://openalex.org/W2149189075","doi":"https://doi.org/10.1186/1476-9255-7-41","title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","display_name":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2149189075","doi":"https://doi.org/10.1186/1476-9255-7-41","mag":"2149189075","pmid":"https://pubmed.ncbi.nlm.nih.gov/20701804","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2928212"},"language":"en","primary_location":{"id":"doi:10.1186/1476-9255-7-41","doi":"https://doi.org/10.1186/1476-9255-7-41","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-9255-7-41","pdf_url":"https://journal-inflammation.biomedcentral.com/counter/pdf/10.1186/1476-9255-7-41","source":{"id":"https://openalex.org/S24701539","display_name":"Journal of Inflammation","issn_l":"1476-9255","issn":["1476-9255"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Inflammation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journal-inflammation.biomedcentral.com/counter/pdf/10.1186/1476-9255-7-41","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111851113","display_name":"Debra M. Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Debra M Meyer","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA. debra.m.meyer@pfizer.com","Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA. debra.m.meyer@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073312039","display_name":"Michael I. Jesson","orcid":"https://orcid.org/0000-0002-2511-4835","observed_orcids":["https://orcid.org/0000-0002-2511-4835"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael I Jesson","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101147257","display_name":"Xiong Li","orcid":"https://orcid.org/0009-0007-3568-7737","observed_orcids":["https://orcid.org/0009-0007-3568-7737"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiong Li","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073844794","display_name":"Mollisa M. Elrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mollisa M Elrick","raw_affiliation_strings":["Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077567836","display_name":"Christie L. Funckes-Shippy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christie L Funckes-Shippy","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005651769","display_name":"James D. Warner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D Warner","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049568155","display_name":"Cindy J. Gross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cindy J Gross","raw_affiliation_strings":["Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003937993","display_name":"Martin E. Dowty","orcid":"https://orcid.org/0000-0003-1393-6388","observed_orcids":["https://orcid.org/0000-0003-1393-6388"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin E Dowty","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112248166","display_name":"Shashi K. Ramaiah","orcid":"https://orcid.org/0009-0007-9105-9970","observed_orcids":["https://orcid.org/0009-0007-9105-9970"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shashi K Ramaiah","raw_affiliation_strings":["Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110015687","display_name":"Jeffrey L. Hirsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey L Hirsch","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082983451","display_name":"Matthew J. Saabye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J Saabye","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080723581","display_name":"Jennifer Barks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer L Barks","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084129668","display_name":"Nandini N. Kishore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nandini Kishore","raw_affiliation_strings":["Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Research, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109685137","display_name":"Dale L. Morris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dale L Morris","raw_affiliation_strings":["Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety R&D, Pfizer Global Research & Development, Chesterfield, MO, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111851113"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":13.5569,"has_fulltext":true,"cited_by_count":462,"citation_normalized_percentile":{"value":0.99334073,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"7","issue":"1","first_page":"41","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.1234000027179718,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.7429999709129333},{"id":"https://openalex.org/keywords/jak3-inhibitors","display_name":"JAK3 inhibitors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.800000011920929},{"id":"https://openalex.org/keywords/adjuvant-induced-arthritis","display_name":"adjuvant-induced arthritis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/granulopoiesis","display_name":"granulopoiesis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.6930000185966492},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":1.0},{"id":"https://openalex.org/keywords/cytokine-signaling","display_name":"cytokine signaling","score":0.6029999852180481},{"id":"https://openalex.org/keywords/paw-edema","display_name":"paw edema","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7007408142089844},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5963695645332336},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5933331251144409},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.5517081618309021},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5065778493881226},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.5033025145530701},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45009973645210266},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.44020792841911316},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.42392492294311523},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.41304588317871094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3664557933807373},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20131409168243408},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1655629575252533},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14150208234786987},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1186/1476-9255-7-41","doi":"https://doi.org/10.1186/1476-9255-7-41","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-9255-7-41","pdf_url":"https://journal-inflammation.biomedcentral.com/counter/pdf/10.1186/1476-9255-7-41","source":{"id":"https://openalex.org/S24701539","display_name":"Journal of Inflammation","issn_l":"1476-9255","issn":["1476-9255"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Inflammation","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2928212","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2928212","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Inflamm (Lond)","raw_type":"Text"},{"id":"pmid:20701804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20701804","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of inflammation (London, England)","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.324.5895","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.324.5895","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.biomedcentral.com/content/pdf/1476-9255-7-41.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:7ca384bc58344d64872584204576a8f0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7ca384bc58344d64872584204576a8f0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Inflammation, Vol 7, Iss 1, p 41 (2010)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1476-9255-7-41","doi":"https://doi.org/10.1186/1476-9255-7-41","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-9255-7-41","pdf_url":"https://journal-inflammation.biomedcentral.com/counter/pdf/10.1186/1476-9255-7-41","source":{"id":"https://openalex.org/S24701539","display_name":"Journal of Inflammation","issn_l":"1476-9255","issn":["1476-9255"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Inflammation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2149189075.pdf","grobid_xml":"https://content.openalex.org/works/W2149189075.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W8963448","https://openalex.org/W72251722","https://openalex.org/W1525055187","https://openalex.org/W1638726768","https://openalex.org/W1888977774","https://openalex.org/W1895277992","https://openalex.org/W1963499278","https://openalex.org/W1963518763","https://openalex.org/W1970091268","https://openalex.org/W1980927217","https://openalex.org/W1984154143","https://openalex.org/W1996493140","https://openalex.org/W2002782759","https://openalex.org/W2011957759","https://openalex.org/W2019931350","https://openalex.org/W2022819740","https://openalex.org/W2027724598","https://openalex.org/W2028580888","https://openalex.org/W2042593266","https://openalex.org/W2044808340","https://openalex.org/W2046710165","https://openalex.org/W2048964610","https://openalex.org/W2050718018","https://openalex.org/W2072479885","https://openalex.org/W2074353882","https://openalex.org/W2077356371","https://openalex.org/W2077800244","https://openalex.org/W2087289184","https://openalex.org/W2093624424","https://openalex.org/W2100772783","https://openalex.org/W2103703668","https://openalex.org/W2105877176","https://openalex.org/W2107003864","https://openalex.org/W2111063314","https://openalex.org/W2113674401","https://openalex.org/W2117926449","https://openalex.org/W2126489971","https://openalex.org/W2133462208","https://openalex.org/W2134965930","https://openalex.org/W2146517830","https://openalex.org/W2154974848","https://openalex.org/W2168444917","https://openalex.org/W2334268564"],"related_works":["https://openalex.org/W7097660216","https://openalex.org/W2107003864","https://openalex.org/W2047299157","https://openalex.org/W2314624306","https://openalex.org/W2163087340","https://openalex.org/W2315231541","https://openalex.org/W2101217991","https://openalex.org/W2063265278","https://openalex.org/W2331968634","https://openalex.org/W1963499278"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,103,225],"Janus":[2],"kinase":[3],"(JAK)":[4],"family":[5],"of":[6,86,99,105,125,183,210,219,228,241,249,263,281,290,302,319,338,347],"tyrosine":[7],"kinases":[8],"includes":[9],"JAK1,":[10],"JAK2,":[11],"JAK3":[12,157,244,266,322],"and":[13,15,23,32,44,75,84,91,136,156,196,199,243,265,305,308,321,340],"TYK2,":[14],"is":[16,29,259],"required":[17],"for":[18,40,88,272],"signaling":[19,153],"through":[20,154,349],"Type":[21,24],"I":[22],"II":[25],"cytokine":[26],"receptors.":[27],"CP-690,550":[28,61,80,87,106,128,150,191,216,229,258,330],"a":[30,97,260],"potent":[31,261],"selective":[33],"JAK":[34,73,171],"inhibitor":[35,262],"currently":[36],"in":[37,54,96,100,115,142,164,176,177,188,207,236,278,327],"clinical":[38],"trials":[39],"rheumatoid":[41],"arthritis":[42,130,146],"(RA)":[43],"other":[45],"autoimmune":[46],"disease":[47],"indications.":[48],"In":[49,121,274],"RA":[50],"trials,":[51],"dose-dependent":[52],"decreases":[53,77],"neutrophil":[55],"counts":[56],"(PBNC)":[57],"were":[58,65,140,205,285,295],"observed":[59,78,187],"with":[60,79,158,173,190,267,317],"treatment.":[62,81,192],"These":[63],"studies":[64],"undertaken":[66],"to":[67,222,336,345],"better":[68],"understand":[69],"the":[70,123,143,208,235,279],"relationship":[71],"between":[72],"selectivity":[74,85,161],"PBNC":[76,135,284,328],"METHODS:":[82],"Potency":[83],"mouse,":[89],"rat":[90,144,275],"human":[92,282],"JAKs":[93],"was":[94,112,186,233,315],"evaluated":[95,141],"panel":[98],"vitro":[101,116,178,237],"assays.":[102,120,180],"effect":[104],"on":[107,129],"granulopoiesis":[108,348],"from":[109,253],"progenitor":[110,203],"cells":[111,204],"also":[113],"assessed":[114],"using":[117],"colony":[118],"forming":[119],"vivo":[122,189],"potency":[124,175,271],"orally":[126],"administered":[127],"(paw":[131],"edema),":[132],"plasma":[133,226],"cytokines,":[134],"bone":[137,200],"marrow":[138,201],"differentials":[139],"adjuvant-induced":[145],"(AIA)":[147],"model.":[148],"RESULTS:":[149],"potently":[151],"inhibited":[152],"JAK1":[155,242,264,320],"5-100":[159],"fold":[160],"over":[162],"JAK2":[163,350],"cellular":[165,270],"assays,":[166],"despite":[167],"inhibiting":[168],"all":[169,218],"four":[170],"isoforms":[172],"nM":[174],"enzyme":[179],"Dose-dependent":[181],"inhibition":[182,318],"paw":[184,303],"edema":[185,304],"Plasma":[193,310],"cytokines":[194,306],"(IL-6":[195],"IL-17),":[197],"PBNC,":[198],"myeloid":[202],"elevated":[206],"context":[209],"AIA":[211],"disease.":[212],"At":[213],"efficacious":[214,231,288],"exposures,":[215],"returned":[217],"these":[220,313],"parameters":[221],"pre-disease":[223],"levels.":[224],"concentration":[227,311],"at":[230,287,312],"doses":[232],"above":[234],"whole":[238],"blood":[239],"IC50":[240],"inhibition,":[245],"but":[246,323],"not":[247,324,343],"that":[248,257],"JAK2.":[250,273,325],"CONCLUSION:":[251],"Results":[252],"this":[254],"investigation":[255],"suggest":[256],"potentially":[268],"reduced":[269],"AIA,":[276],"as":[277,298],"case":[280],"RA,":[283],"decreased":[286],"exposures":[289,314],"CP-690,550.":[291],"Inflammatory":[292],"end":[293],"points":[294],"similarly":[296],"reduced,":[297],"judged":[299],"by":[300],"attenuation":[301,337],"IL-6":[307],"IL-17.":[309],"consistent":[316],"Decreases":[326],"following":[329],"treatment":[331],"may":[332],"thus":[333],"be":[334],"related":[335],"inflammation":[339],"are":[341],"likely":[342],"due":[344],"suppression":[346],"inhibition.":[351]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":23},{"year":2024,"cited_by_count":27},{"year":2023,"cited_by_count":22},{"year":2022,"cited_by_count":33},{"year":2021,"cited_by_count":33},{"year":2020,"cited_by_count":37},{"year":2019,"cited_by_count":48},{"year":2018,"cited_by_count":36},{"year":2017,"cited_by_count":41},{"year":2016,"cited_by_count":32},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":33},{"year":2013,"cited_by_count":28},{"year":2012,"cited_by_count":26}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}